Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
Ji-Youn Chun, Miho Song, Ji-Yeon Han, Selee Na, Bumsik Hong, Myung-Soo Choo
Int Neurourol J. 2014;18(1):23-30. Published online 2014 Mar 31 DOI: https://doi.org/10.5213/inj.2014.18.1.23
Citations to this article as recorded by 
Efficacy of a combination of dutasteride, tadalafil, and solifenacin in the treatment of previously unsuccessful patients
Kirill Kosilov, Irina Kuzina, Vladimir Kuznetsov, Olga Barabash, Ekaterina Fedorishcheva
Asian Journal of Urology.2022; 9(1): 42. CrossRef
Validating 7-items Overactive Bladder Symptom Score (OABSS) through Arabic linguistic version
Fadi Sawaqed, Mohammed Suoub
Scientific Reports.2021;[Epub] CrossRef
Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting
Marjan Amiri, Tim Schneider, Matthias Oelke, Sandra Murgas, Martin C. Michel
Journal of Clinical Medicine.2021; 10(2): 311. CrossRef
Dose Pattern Evolution and Therapeutic Benefit in Patients on Solifenacin or Fesoterodine Treatment in Daily Clinical Practice
José M. García-Mediero, Francisco Sánchez-Ballester, Daniel Arumi, Isabel Lizarraga
Open Journal of Urology.2016; 06(06): 91. CrossRef
Influence of different doses of trospium and solifenacin on manageability of OAB symptoms with different severity in elderly men and women
Kirill V Kosilov, Sergey A Loparev, Marina A Ivanovskaya, Liliya V Kosilova
Journal of Clinical Urology.2016; 9(3): 180. CrossRef
The efficacy of different doses of solifenacin in elderly patients after treating a urinary tract infection
Kirill V. Kosilov, Sergay A. Loparev, Marina A. Ivanovskaya, Liliya V. Kosilova
Arab Journal of Urology.2015; 13(3): 203. CrossRef